Blood biochemical parameters in transfer factor donor cows depending on sensitization scheme

Authors

DOI:

https://doi.org/10.31548/ujvs2020.04.009

Keywords:

transfer factor, sensitization, cows, blood

Abstract

Research and development of means for effective prevention and treatment of diseases in animals are one of the priorities for modern veterinary science. Means based on the transfer factor are quite promising to solve these problems. One of the stages of obtaining a qualitative transfer factor specific to a particular disease is the sensitization of the body of donor animals. The purpose of this work was to investigate the blood biochemical parameters of donor cows after sensitization according to different schemes. The experiments were performed on cows of the Ukrainian black-spotted dairy breed, aged 4–5 years. Sensitization of pregnant cows was performed 1–1.5 months before calving with a concentrated formol-alum vaccine against salmonellosis of calves manufactured by the Kherson Biofactory. The vaccine was administered to the animals of the first experimental group one month before calving, one-time in a dose of 10 ml. Animals of the second experimental group 1.5 months before calving were two-time vaccine administered with an interval between injections of 10 days in doses of 10 and 15 ml. Studies have shown that in donor cows, which were two-time vaccine administered, there was an increase in hemoglobin content by 13% (P<0.05). There was also a decrease in glucose and creatinine content by 13–28% (P<0.05–0.01) in the blood serum of pregnant cows, which did not depend on the sensitization scheme, and a tendency to a decrease in total protein content. Regardless of the sensitization scheme of cows, an increase in serum aminotransferase activity was observed by 1.3–1.5 times (P<0.05–0.001), and if alanine aminotransferase activity increased mainly with a single injection of the vaccine, then aspartate aminotransferase activity was more intensively increased after a two-time vaccine administration. There was a slight decrease in сalcium (by 5–9%) and phosphorus (by 2–3%) content and an increase in potassium content (by 2–5%) in the blood serum of pregnant cows two weeks after vaccine administration regardless of the sensitization scheme.

References

Chen, H., Gao, N., Fan, D., Wu, J., Zhu, J., Li, J., ... & An, J. (2012). Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice. PLoS One, 7(4), e34602.

https://doi.org/10.1371/journal.pone.0034602

Fudenberg, H. H., & Pizza, G. (1994). Transfer factor 1993: new frontiers. Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques, 309-400.

https://doi.org/10.1007/978-3-0348-7153-2_7

Galbraith, G., & Fudenberg, H. (1985). Transfer Factor. Dermatology, Immunology and Allergy, 3, 889-898.

García-Hernández, U., Robledo-Ávila, F. H., Álvarez-Jiménez, V. D., Rodríguez-Cortés, O., Wong-Baeza, I., Serafín-López, J., ... & Chacón-Salinas, R. (2014). Dialyzable leukocyte extracts activate TLR-2 on monocytes. Natural Product Communications, 9(6), 1934578X1400900633.

https://doi.org/10.1177/1934578X1400900633

Kirkpatrick, C. H. (1993). Structural nature and functions of transfer factors. Annals of the New York Academy of Sciences, 685(1), 362-368.

https://doi.org/10.1111/j.1749-6632.1993.tb35889.x

Krishnaveni, M. (2013). A review on transfer factor an immune modulator. Drug Invention Today, 5(2), 153-156.

https://doi.org/10.1016/j.dit.2013.04.002

Lara, H. H., Ixtepan-Turrent, L., Garza-Treviño, E. N., Tamez-Guerra, R., & Rodriguez-Padilla, C. (2010). Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant. Experimental and Therapeutic Medicine, 1(3), 425-431. doi: 10.3892/etm_00000066

https://doi.org/10.3892/etm_00000066

Lawrence, H. S. (1955). The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes. The Journal of Clinical Investigation, 34(2), 219-230.

https://doi.org/10.1172/JCI103075

Petrov, R. V., Khaitov, R. M., Manko, V. M., Cheredeev, A. N., Vorobiev, A. A., & Trunova, L. A. (1994). Otsenka immunnogo statusa, immunologicheskiy monitoring-sovremennyie problemyi klinicheskoy immunologii i allergologii [Assessment of the immune status, immunological monitoring - modern problems of clinical immunology and allergology]. Immunology, 15(6), 4-6.

Rozzo, S. J., & Kirkpatrick, C. H. (1992). Purification of transfer factors. Molecular immunology, 29(2), 167-182.

https://doi.org/10.1016/0161-5890(92)90098-I

Sell, S., Berkower, I., & Max, E. E. (1996). Immunology, immunopathology and immunity. Stamford. CT: Appleton a Lange.

Viza, D., Fudenberg, H. H., Palareti, A., Ablashi, D., De Vinci, C., & Pizza, G. (2013). Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases. Folia biologica, 59(2), 53.

Vlizlo, V. V., Fedoruk, R. S., & Ratych, I. B. (2012). Laboratorni metody doslidzhen u biolohiyi, tvarynnytstvi ta veterynarniy medytsyni [Laboratory methods of investigation in biology, stock-breeding and veterinary]. Spolom, Lviv.

Downloads

Issue

Section

Article